Search Results - "Burstein ES"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Discovery of novel SSRIs for a combination-treatment with pimavanserin.

    Authors: Kers A Gabos B Borhade S et al.

    Source: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2026 Aug; Vol. 137, pp. 130662. Date of Electronic Publication: 2026 Apr 17.

    Publication Type: Journal Article

    Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9107377 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-3405 (Electronic) Linking ISSN: 0960894X NLM ISO Abbreviation: Bioorg Med Chem Lett Subsets: MEDLINE

    Save to List
  2. 2

    Nonclinical Characterization of ACP-204, a Novel Selective 5-HT2A Receptor Inverse Agonist.

    Authors: Burstein ES Olsson R Skold N et al.

    Source: The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2026 Jun; Vol. 393 (6), pp. 104932. Date of Electronic Publication: 2026 May 05.

    Publication Type: Journal Article

    Journal Info: Publisher: American Society for Pharmacology and Experimental Therapeutics Country of Publication: Netherlands NLM ID: 0376362 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-0103 (Electronic) Linking ISSN: 00223565 NLM ISO Abbreviation: J Pharmacol Exp Ther Subsets: MEDLINE

    Save to List
  3. 3

    Imaging the 5-HT2C receptor with PET: Evaluation of 5-HT2C and 5-HT2A affinity of pimavanserin in the primate brain.

    Authors: Ridler K Rizzo G Burstein ES et al.

    Source: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism [J Cereb Blood Flow Metab] 2025 Feb; Vol. 45 (2), pp. 352-364. Date of Electronic Publication: 2024 Aug 21.

    Publication Type: Journal Article

    Journal Info: Publisher: SAGE Publications Country of Publication: United States NLM ID: 8112566 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-7016 (Electronic) Linking ISSN: 0271678X NLM ISO Abbreviation: J Cereb Blood Flow Metab Subsets: MEDLINE

    HTML Full Text PDF Full Text
    Save to List
  4. 4

    The impact of pimavanserin on psychotic phenotypes and tau phosphorylation in the P301L/COMT- and rTg(P301L)4510 mouse models of Alzheimer's disease.

    Authors: Jimenez H Adrien L Wolin A et al.

    Source: Alzheimer's & dementia (New York, N. Y.) [Alzheimers Dement (N Y)] 2022 Feb 01; Vol. 8 (1), pp. e12247. Date of Electronic Publication: 2022 Feb 01 (Print Publication: 2022).

    Publication Type: Journal Article

    Journal Info: Publisher: Wiley on behalf of the Alzheimer's Association Country of Publication: United States NLM ID: 101650118 Publication Model: eCollection Cited Medium: Internet ISSN: 2352-8737 (Electronic) Linking ISSN: 23528737 NLM ISO Abbreviation: Alzheimers Dement (N Y) Subsets: PubMed not MEDLINE

    PDF Full Text
    Save to List
  5. 5

    Pimavanserin reverses multiple measures of anxiety in a rodent model of post-traumatic stress disorder.

    Authors: Malin DH Tsai PH Campbell JR et al.

    Source: European journal of pharmacology [Eur J Pharmacol] 2023 Jan 15; Vol. 939, pp. 175437. Date of Electronic Publication: 2022 Dec 09.

    Publication Type: Journal Article

    Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 1254354 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0712 (Electronic) Linking ISSN: 00142999 NLM ISO Abbreviation: Eur J Pharmacol Subsets: MEDLINE

    Save to List

Search Tools: